Bartizal Ken
Insider CIK 1478832 · TSRX Chief Development Officer · CDTX Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2017-03-31 | 2017-04-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2016-03-16 | 2016-03-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 40,000 | $10.00 | $400.0K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 6,395 | $12.21 | $78.1K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 16,569 | $12.21 | $202.3K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 75,000 | $8.70 | $652.5K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 90,000 | $7.37 | $663.3K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer | 2013-09-11 | 2013-09-13 | 96,400 | — | $0 | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | S Sale | 2013-07-01 | 2013-07-01 | 2,000 | $8.14 | $16.3K | 95,300 | SEC↗ |
| TSRX Trius Therapeutics Inc | S Sale | 2013-06-04 | 2013-06-04 | 2,000 | $7.90 | $15.8K | 97,300 | SEC↗ |
| TSRX Trius Therapeutics Inc | S Sale | 2013-05-24 | 2013-05-28 | 12,000 | $7.93 | $95.2K | 98,927 | SEC↗ |
| TSRX Trius Therapeutics Inc | S Sale | 2013-05-14 | 2013-05-16 | 12,000 | $7.85 | $94.2K | 98,927 | SEC↗ |
| TSRX Trius Therapeutics Inc | S Sale | 2013-05-14 | 2013-05-28 | 12,000 | $7.85 | $94.2K | 110,927 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2013-03-07 | 2013-03-11 | 90,000 | — | $0 | 90,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2012-03-08 | 2012-03-12 | 75,000 | — | $0 | 75,000 | SEC↗ |